Olema Oncology is a preclinical biotechnology company that develops new drugs for the treatment and prevention of breast cancer. Founded by Cyrus L. Harmon and Peter Kushner in 2007, Olema Oncology is backed by investors that include BlackRock, Wellington Management, OrbiMed, RA Capital Management, and Surveyor Capital and is headquartered in San Francisco.
FOUNDED:
2007
INDUSTRY:
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
FOUNDERS:
Cyrus L. Harmon, Peter Kushner
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
